AI assistant
Sending…
Sopharma AD — Earnings Release 2024
Apr 22, 2024
2543_rns_2024-04-22_b3f7bbc0-9646-4ac0-b4e3-4d9c8a69821a.pdf
Earnings Release
Open in viewerOpens in your device viewer
Current report № 21/ 2024 Dated April 22, 2024
NOTIFICATION
"Sopharma" AD (the Company) notifies that for March 2024 the Company recorded a decrease in sales of 24% compared to the same month of the previous year, incl. 8% decrease in domestic sales and 32% decrease in export sales, mainly due to destabilizing market dynamics on the main export destinations.
From the beginning of 2024, the Company recorded a decrease in sales of 11%, incl. 1% decrease of domestic sales and 16% decrease in export sales.
Ognian Donev
More from Sopharma AD
Transaction in Own Shares
2026
Jun 1
Regulatory Filings
2026
May 29
Transaction in Own Shares
2026
May 29
Transaction in Own Shares
2026
May 28
Transaction in Own Shares
2026
May 27
Transaction in Own Shares
2026
May 26
Transaction in Own Shares
2026
May 22
Regulatory Filings
2026
May 21
Transaction in Own Shares
2026
May 21
Regulatory Filings
2026
May 20